CompoAtlas

Gemmothérapie Confort Femme 50+

Food supplement declared in France, declaration No 2019-8-110, decision dated 2 August 2019

Gemmothérapie Confort Femme 50+ (AROMAYA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium vitis-idaea 25 mg per day, Rubus fruticosus 12 mg per day, Malus sylvestris 8 mg per day, Crataegus laevigata 5 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
AROMAYA
Food business operator placing the product on the market
SIRIUS
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
360
Directions for use
15 gouttes par jour, pures ou diluées
Objectives stated by the manufacturer (these are not authorised claims)
Menopause

Declaration 165079, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Vaccinium vitis-idaea L.Young shootOther macerate25 mg
Rubus fruticosus L.Young shootOther macerate12 mg
Malus sylvestris Mill.BudOther macerate8 mg
Crataegus laevigata (Poir.) DC.Leaf (bud)Other macerate5 mg

Additives

E422

Other ingredients

Alcool, eau

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ne pas dépasser la dose journalière recommandée. Ce produit est un complément alimentaire et ne se substitue pas à un mode de vie sain, ni à une alimentation variée et équilibrée, ni à un suivi médical. Tenir hors de portée des enfants. Déconseillé chez les femmes enceintes ou allaitant. Conserver le flacon dans son étui, dans un endroit frais et sec, à l’abri de la lumière. Un dépôt naturel peut être visible, mais n’altère en rien la qualité du produit.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : AROMAYA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Gemmothérapie Confort Femme 50+ (AROMAYA): composition and regulation”, https://compoatlas.com/en/supplements/products/165079-gemmotherapie-confort-femme-50, updated 15 November 2026.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line